Prelude Therapeutics's total assets for Q1 2025 were $141.26M, a decrease of -19.52% from the previous quarter. PRLD total liabilities were $38.08M for the fiscal quarter, a -13.56% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.